Agilent Technologies, Inc. $A Stock Holdings Lifted by Generation Investment Management LLP

Key Points

• Generation Investment Management LLP increased its holdings in Agilent Technologies, Inc. by 19.8% in Q1, owning 4,983,556 shares worth approximately $582.98 million.
• Agilent Technologies reported a 10.1% year-over-year increase in revenue, totaling $1.74 billion, and matched earnings expectations with an EPS of $1.37.
• Analysts have mixed ratings on Agilent Technologies, with price targets ranging from $130 to $150, reflecting a generally optimistic outlook despite some downward adjustments.

Generation Investment Management LLP lifted its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 19.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,983,556 shares of the medical research company's stock after purchasing an additional 824,243 shares during the period. Agilent Technologies comprises approximately 3.5% of Generation Investment Management LLP's portfolio, making the stock its 13th largest position. Generation Investment Management LLP owned approximately 1.75% of Agilent Technologies worth $582,976,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of A. Whipplewood Advisors LLC lifted its position in shares of Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after purchasing an additional 186 shares during the last quarter. Sunbelt Securities Inc. lifted its position in shares of Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after purchasing an additional 192 shares during the last quarter. Stone House Investment Management LLC acquired a new stake in Agilent Technologies during the 1st quarter worth $30,000. Opal Wealth Advisors LLC acquired a new stake in Agilent Technologies during the 1st quarter worth $31,000. Finally, Wood Tarver Financial Group LLC acquired a new stake in Agilent Technologies during the 4th quarter worth $34,000.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Agilent Technologies Trading Up 0.2%

Shares of Agilent Technologies stock traded up $0.21 during trading hours on Friday, hitting $128.69. The company's stock had a trading volume of 1,633,203 shares, compared to its average volume of 1,522,644. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The business has a fifty day moving average of $119.22 and a 200 day moving average of $116.34. The company has a market capitalization of $36.48 billion, a PE ratio of 30.21, a P/E/G ratio of 4.00 and a beta of 1.24. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Analyst Upgrades and Downgrades

A has been the topic of several research analyst reports. Barclays reiterated an "equal weight" rating and set a $125.00 price target on shares of Agilent Technologies in a research note on Friday, August 29th. TD Cowen lifted their price target on shares of Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Robert W. Baird lifted their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research note on Thursday, August 28th. Wall Street Zen lowered shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Friday. Finally, Evercore ISI dropped their price objective on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a research note on Thursday, August 28th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $139.25.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.